SNMMI is a global and collaborative scientific organization dedicated to both the practice and the science of nuclear medicine and molecular imaging and therapy around the world. SNMMI's worldwide membership totals more than 15,000, including physicians, scientists, technologists, chemists, radiopharmacists, students and industry representatives from 82 countries around the world.
The SNMMI 2018 Annual Meeting—the premier educational, scientific, research, and networking event in nuclear medicine and molecular imaging—provides physicians, technologists, pharmacists, laboratory professionals, and scientists with an in-depth view of the latest research and development in the field as well as providing insights into practical applications for the clinic. Register today to join 5,000+ attendees from more than 60 countries!
The SNMMI Annual Meeting helps you increase your professional effectiveness as you learn to:
Now Available! View Sessions and Personalize Your Schedule
*Important Notice: We are pleased to announce that SNMMI’s 2018 Annual Meeting App is being provided by a new company and includes many enhancements. All users will need to download the new app.
Viewing this page on your mobile device/tablet? Download the Annual Meeting App.
SNMMI is a global and collaborative scientific organization dedicated to both the practice and the science of nuclear medicine and molecular imaging and therapy around the world. SNMMI's worldwide membership totals over 20,000, which includes physicians, scientists, technologists, chemists, radiopharmacists, students and industry representatives from more than 84 countries around the world. SNMMI's Journal of Nuclear Medicine (JNM), the premier international journal of nuclear medicine, reaches over 17,000 individuals each month. SNMMI's Annual Meeting is nuclear medicine's and molecular imaging's largest gathering each year, attracting over 5,000 professional attendees and another 2,500 industry representatives.
At the most recent Annual Meeting in June 2016 in San Diego, California, 35% of registered attendees were from countries other than the United States. Attendees represented over 65 countries. In addition, abstract submissions for SNMMI's Annual Meeting from outside the United States represent close to 67% of all submissions.
While SNMMI's headquarters office resides in Virginia, just outside of Washington, D.C., its perspective, programs, and growth are as international as its members. As of 2017, 12% of the Society's members reside in more than 84 countries other than the United States.
Search for an international nuclear medicine and molecular imaging organization near you.
SNMMI's educational programs and activities reflect the increasing importance and participation of its international members. Such common global nuclear medicine and molecular imaging and therapy issues as quality of care, educating referring physicians and patients, and exploring ways to better share developments in the practice of nuclear medicine and molecular imaging and therapy are but a few of the activities currently underway by Society staff, Committees, Councils, and our Centers of Excellence. This website seeks to constantly expand its offerings to the Society's international members, providing an ever-changing, updated array of global resources and news for nuclear medicine and molecular imaging and therapy professionals literally anywhere on the globe.
SNMMI continues to stay actively involved in several jointly sponsored educational programs and educational outreach activities with regional nuclear medicine and molecular imaging and therapy organizations around the world; both in their home countries, and during SNMMI's Annual Meeting. These joint sponsored programs include not only the sharing of speakers and renown experts on all facets of nuclear medicine and molecular imaging, collaboration on the development of enduring educational materials, and programmatic/administrative support, but also include translation of materials and website development.
Each year, the SNMMI collaborates with international organizations in an effort to continue the exchange of ideas, education and knowledge. Intiatives include:
Nuclear Medicine Global Initiative
3rd Sino-American Conference
Chinese/U.S. Resident Exchange Program
IAEA CT Case Webinar Series
EANM Collaborative Guidelines
SNMMI offers a Full International Membership category for international colleagues. Learn more on how to become an SNMMI Full Member (international).
Available to physicians, scientists or pharmacists possessing an advanced degree who have presented credentials indicating their professional activity, either, medical, paramedical, investigational or educational in the scientific or clinical disciplines of molecular imaging or nuclear medicine. This includes the diagnostic, therapeutic or investigational use of radionuclides or other molecular imaging technologies.
Annual dues: $510
Includes subscription to The Journal of Nuclear Medicine.
Includes voting rights and can be elected an Officer of the SNMMI.
Corresponding Country Discount
In an effort to make membership more accessible to nuclear medicine and molecular imaging professionals around the world, SNMMI’s corresponding country category gives members of eligible countries an 80% discount on dues. See discount breakdown.
80% discount on all membership categories
Online access to The Journal of Nuclear Medicine.
Voting rights and can be elected an Officer of the SNMMI.
As part of its continuing commitment to growing the practice of nuclear medicine and molecular imaging and therapy worldwide, SNMMI leadership works diligently to develop strategic alliances with key regional nuclear medicine organizations to assist these groups in expanding the scope and quality of nuclear medicine outside the United States. These strategic alliances stretch across the globe. reaching every continent where SNMMI's members reside and practice.
SNMMI Partners and Alliances Include:
For more information on SNMMI's international activities and programs, please contact:
Nikki Wenzel-Lamb, MBA Director of Leadership Direct: 703-652-6766 Fax: 703-708-9020 Email: email@example.com
Congressman Loebsack and staff visited the PET and nuclear medicine facilities at the University of Iowa.
(Government Relations News)
Researchers have identified two new nuclear medicine tracers that make it easier to diagnose and potentially treat multiple types of cancer, providing high-quality images with less patient preparation and shorter acquisition times.
Nuclear medicine imaging with PET/CT can monitor the effectiveness of immunotherapy treatment for metastatic melanoma and predict outcome. In this way, a patient’s therapy can be more effectively tailored to his or her personal response.
On March 1, the U.S. Food and Drug Administration announced updates to the categories of bulk drug substances under its interim policy under section 503B of the Federal Food, Drug, and Cosmetic Act. SNMMI commends the FDA for their swift action to update the 503B Bulk Drugs list, which will ultimately make it easier for manufacturers to compound and make available an arginine/lysine only solution.
(Government Relations News)
SNMMI is excited to welcome China as our 2018 “Highlight Country.” The Chinese Society will showcase the culture and food of China in the Highlight Country Lounge during the Welcome Reception. They have also organized continuing education sessions, and will present a record number of oral and poster presentations during the meeting.
Look for the Highlight Country floor stickers when visiting the Poster Hall to learn more about the great research that is being done there.
Tools, supported by evidence, to harmonize the practice of nuclear medicine using a progressive and safe approach.
Learn more about journals published by or sponsored by the Society of Nuclear Medicine and Molecular Imaging.